A similar mechanism has been described in ABC DLBCL, where a signaling complex composed of MYD88, TLR9, and IgM has been identified in the endolysosomal compartment of MYD88-mutated cells [97]. Here, MYD88 is linked to diffuse large B-cell lymphoma.